Cart
sales@molnova.com
Home - Products - MAPK/ERK Signaling - MEK - Nedometinib

Nedometinib

Nedometinib

Catalog No. M37153

Nedometinib (NFX-179) is a selective mitogen-activated protein kinase kinase (MEK1) inhibitor with anticancer and antitumor activity, inhibits MAPK pathway signaling in the skin, inhibits the growth of human squamous cell lines in a dose-dependent manner, and can be used to study malignant tumors.

Size Price / USD Stock Quantity
2MG 103 Get Quote
5MG 154 Get Quote
10MG 226 Get Quote
25MG 361 Get Quote
50MG 615 Get Quote
100MG 981 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote
Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Nedometinib
  • Brief Description
  • Description
  • Storage
  • Note
    Research use only, not for human use.
  • Reference
    1. Kincaid, et al. Preparation of pyrrolopyridine-aniline compounds for treatment of dermal disorders. World Intellectual Property Organization, WO2018213810 A1. 2018-11-22.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Tpl2-IN-34

    A potent, selective Tpl2 (cot/MAP3K8) inhibitor with IC50 of 1.6 nM.

  • DLK-IN-14

    A potent, selective, CNS penetrant dual leucine zipper kinase (DLK, MAP3K12) inhibitor with Ki of 3 nM.

  • PD318088

    PD318088 is a potent, non-ATP competitive, allosteric MEK1/2 inhibitor.

Sign In Join Free